Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18F]ISO-1 PET/CT-Reference-Cited by-同舟云学术

Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18F]ISO-1 PET/CT

Published:2019-01-28 Issue:10 Volume:25 Page:3063-3073
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Elmi Azadeh,Makvandi Mehran,Weng Chi-Chang,Hou Catherine,Clark Amy S.,Mach Robert H.,Mankoff David A.

Funder

RSNA Research and Educational FoundationRSNA Research and Educational Foundation (RSNA R&E Foundation)

Susan G. Komen for the CureSusan G. Komen for the Cure (Susan G. Komen)

HHS | National Institutes of HealthHHS | National Institutes of Health (NIH)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positron Emission Tomography Imaging of Tumor Proliferation and DNA Repair;The Cancer Journal;2024-05

2. RBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities;Experimental Cell Research;2024-02

3. Impact of PET and PET/CT Radiotracer for Evaluating Efficacy of CDK4/6 Inhibitor Therapy in HR-Positive HER2-Negative Metastatic Breast Cancer;IFMBE Proceedings;2024

4. 18F-FES and 18F-FDG PET/CT imaging as a predictive biomarkers for metastatic breast cancer patients undergoing cyclin-dependent 4/6 kinase inhibitors with endocrine treatment;Annals of Nuclear Medicine;2023-10-03

5. Preparation and Evaluation of [¹⁸F]AlF-NOTA-PBB for PET Imaging of Cyclin-dependent Kinase 4/6 in Tumors;Molecular Pharmaceutics;2023-08-24